Тёмный
No video :(

Lecanemab for Treatment of Early Alzheimer’s Disease: Overview & Clinician Perspectives 

Johns Hopkins ADRC
Подписаться 452
Просмотров 9 тыс.
50% 1

This recording of our Spring, 2023 seminar features a presentation by Dr. Barry Greenberg on the topic of Lecanemab, followed by a panel discussion with two dementia experts, Drs. Chiadi Onyike and Paul Rosenberg.
This educational program was the result of collaborations between multiple groups at Morgan State University and Johns Hopkins. It was presented by Morgan State University's RCMI, ASCEND, and School of Computer, Mathematical and Natural Sciences, and was co-sponsored by Morgan CARES, the Johns Hopkins Alzheimer’s Disease Research Center, and the Johns Hopkins Alzheimer’s Disease Resource Center for Minority Aging Research.

Опубликовано:

 

27 апр 2023

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии    
Далее
What's Lecanemab and what's next?
59:20
Просмотров 3,4 тыс.
A Closer Look at Lecanemab, Donanemab and Amyloid
54:22
Leqembi Vs Donanemab: Cure for Alzheimer's?
28:27
Просмотров 3,5 тыс.
Dementia and Cognitive Decline - A Brief Overview
13:31
Memories for Life: Reversing Alzheimer's
45:11
Просмотров 13 тыс.